The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Thoas Fioretos

Thoas Fioretos

Research team manager

Thoas Fioretos

IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate ETV6::RUNX1-positive leukemia cells in preclinical models.

Author

  • Helena Ågerstam
  • Henrik Lilljebjörn
  • Marianne Rissler
  • Carl Sandén
  • Thoas Fioretos

Department/s

  • LUCC: Lund University Cancer Centre
  • Translational Genomic and Functional Studies of Leukemia
  • Lund University Bioimaging Center

Publishing year

2023-02-01

Language

English

Pages

599-604

Publication/Series

Haematologica

Volume

108

Issue

2

Document type

Journal article

Publisher

Ferrata Storti Foundation

Topic

  • Hematology
  • Cancer and Oncology

Keywords

  • Child
  • Humans
  • Core Binding Factor Alpha 2 Subunit/genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • Oncogene Proteins, Fusion/genetics
  • Interleukin-1 Receptor Accessory Protein

Status

Published

Research group

  • Translational Genomic and Functional Studies of Leukemia

ISBN/ISSN/Other

  • ISSN: 1592-8721